CliffBio
small molecule

ENSKYCE

DESOGESTREL; ETHINYL ESTRADIOL

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameENSKYCE
Active ingredientDESOGESTREL; ETHINYL ESTRADIOL
Strength0.15MG;0.03MG
Dosage formTABLET
RouteORAL-28
ModalitySmall molecule
FDA approvalMarch 2013
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.